Flagship V VentureLabs Rx Fund, L.P.'s Net Worth
$211 Million
Who is Flagship V VentureLabs Rx Fund, L.P.?
Flagship V VentureLabs Rx Fund, L.P. has an estimated net worth of $211 Million. This is based on reported shares across multiple companies, which include Sana Biotechnology, Inc., Omega Therapeutics, Inc., Codiak BioSciences, Inc., Evelo Biosciences, Inc., and Rubius Therapeutics, Inc..
SEC CIK
Flagship V VentureLabs Rx Fund, L.P.'s CIK is 0001724939
Past Insider Trading and Trends
2021 was Flagship V VentureLabs Rx Fund, L.P.'s most active year for acquiring shares with 13 total transactions. Flagship V VentureLabs Rx Fund, L.P.'s most active month to acquire stocks was the month of June. 2018 was Flagship V VentureLabs Rx Fund, L.P.'s most active year for disposing of shares, totalling 16 transactions. Flagship V VentureLabs Rx Fund, L.P.'s most active month to dispose stocks was the month of April. 2021 saw Flagship V VentureLabs Rx Fund, L.P. paying a total of $19,999,973.00 for 57,944,228 shares, this is the most they've acquired in one year. In 2023 Flagship V VentureLabs Rx Fund, L.P. cashed out on 12,730,275 shares for a total of $6,060,133.46, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Sana Biotechnology, Inc. (SANA) Snapshot price: $6.155
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -32.03% | -11.78M |
—
|
—
| 25M |
Sep 13
| |||
Form 4
| -3.22% | -403.76K |
$6.27 | -$2,532,858.32 | 12.12M |
Jun 6 - Jun 7
| |||
Form 4
| -4.17% | -545.24K |
$6.47 | -$3,527,275.14 | 12.53M |
May 24 - May 26
| |||
Form 4
|
∞
| 34.24M |
—
|
—
| 34.24M |
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Rubius Therapeutics, Inc. (RUBY) Snapshot price: $0.057
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +185.29% | 33.3M |
—
|
—
| 51.27M |
Jul 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Codiak BioSciences, Inc. (CDAKQ) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +44.00% | 933.33K |
—
|
—
| 3.05M |
Sep 15
| |||
Form 4
| +148.76% | 2.12M |
$15.00 |
—
| 3.55M |
Oct 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Evelo Biosciences, Inc. (EVLO) Snapshot price: $0.04
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +447.55% | 14.9M |
$16.00 | $4,500,000.00 | 18.23M |
May 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Omega Therapeutics, Inc. (OMGA) Snapshot price: $3.58
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 23.71M |
$17.00 |
—
| 23.71M |
Aug 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||